BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.300
0.00 (0.00%)
At close: Oct 15, 2026
BioAtla Employees
BioAtla had 41 employees as of December 31, 2025. The number of employees decreased by 20 or -32.79% compared to the previous year. That makes BioAtla the 35,830th largest employer in the world and 4,879th in the United States.
Employees
41
Change (1Y)
-20
Growth (1Y)
-32.79%
Revenue / Employee
$207,317
Profits / Employee
-$767,171
Market Cap
2.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -20 | -32.79% |
| Dec 31, 2024 | 61 | -4 | -6.15% |
| Dec 31, 2023 | 65 | -1 | -1.52% |
| Dec 31, 2022 | 66 | 10 | 17.86% |
| Dec 31, 2021 | 56 | 20 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 214 |
| International Stem Cell | 33 |
| Aditxt | 26 |
| Mosaic ImmunoEngineering | 7 |
| America Great Health | 5 |
| AccuStem Sciences | 4 |
| Abpro Holdings | 3 |
| Bioxytran | 2 |
BioAtla News
- 2 months ago - BioAtla Quarterly report: Q2 2026 - Filings
- 4 months ago - BioAtla Proxy statement: Proxy filing - Filings
- 4 months ago - BioAtla Proxy statement: Proxy filing - Filings
- 5 months ago - Context Therapeutics enters license agreement amendment with BioAtla - TheFly
- 5 months ago - BioAtla Quarterly report: Q1 2026 - Filings
- 6 months ago - BioAtla trading halted, news pending - TheFly
- 6 months ago - BioAtla announces 50-for-1 share consolidation - TheFly
- 6 months ago - BioAtla Announces Share Consolidation - GlobeNewsWire